Riluzole attenuates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus.
The rapid emergence and dissemination of antibiotic resistance in Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), pose a major global health challenge and call for alternative therapeutic strategies. S. aureus uses staphyloxanthin (STX) and biofilm as complementary virulence-associated traits...